ATE113993T1 - Menschliche dns für die diagnose von glioma- retinae. - Google Patents

Menschliche dns für die diagnose von glioma- retinae.

Info

Publication number
ATE113993T1
ATE113993T1 AT87307095T AT87307095T ATE113993T1 AT E113993 T1 ATE113993 T1 AT E113993T1 AT 87307095 T AT87307095 T AT 87307095T AT 87307095 T AT87307095 T AT 87307095T AT E113993 T1 ATE113993 T1 AT E113993T1
Authority
AT
Austria
Prior art keywords
retinae
glioma
diagnosis
human dna
dna
Prior art date
Application number
AT87307095T
Other languages
English (en)
Inventor
Thaddeus P Dryja
Stephen Friend
Original Assignee
Massachusetts Eye & Ear Infirm
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye & Ear Infirm, Whitehead Biomedical Inst filed Critical Massachusetts Eye & Ear Infirm
Application granted granted Critical
Publication of ATE113993T1 publication Critical patent/ATE113993T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87307095T 1986-08-11 1987-08-11 Menschliche dns für die diagnose von glioma- retinae. ATE113993T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89516386A 1986-08-11 1986-08-11

Publications (1)

Publication Number Publication Date
ATE113993T1 true ATE113993T1 (de) 1994-11-15

Family

ID=25404097

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94103625T ATE230442T1 (de) 1986-08-11 1987-08-11 Menschliche dns zum nachweis von retinoblastoma
AT87307095T ATE113993T1 (de) 1986-08-11 1987-08-11 Menschliche dns für die diagnose von glioma- retinae.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94103625T ATE230442T1 (de) 1986-08-11 1987-08-11 Menschliche dns zum nachweis von retinoblastoma

Country Status (7)

Country Link
EP (2) EP0259031B1 (de)
JP (4) JP2779161B2 (de)
AT (2) ATE230442T1 (de)
AU (1) AU600293B2 (de)
CA (1) CA1341576C (de)
DE (2) DE3752360T2 (de)
ES (2) ES2063739T3 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712646D0 (en) * 1987-05-29 1987-07-01 Clayton Found Res Structural evidence
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
DE68928728T2 (de) * 1988-01-21 1998-12-10 Massachusetts Eye & Ear Infirmary, Boston, Mass. Diagnose von retinoblastoma
ATE108491T1 (de) * 1988-03-18 1994-07-15 Baylor College Medicine Mutationsnachweis durch kompetitiven oligonukleotid-priming.
JP2706667B2 (ja) * 1988-10-06 1998-01-28 株式会社セラリカ野田 抗 体
DE69032864T3 (de) * 1989-03-29 2013-01-31 The Johns Hopkins University Nachweis des Ausfalls des Wildtyps des p53-Gens
CA2014473A1 (en) * 1989-04-14 1990-10-14 Hong-Ji Xu Purified, highly specific antibodies against gene products including retinoblastoma and method
US5262321A (en) * 1991-05-31 1993-11-16 Dana-Farber Cancer Institute DNA encoding p107 tumor suppressor
TW346397B (en) * 1991-10-17 1998-12-01 Univ California Cell cycle controlling compositions and methods of using same
JPH08506001A (ja) * 1992-10-01 1996-07-02 ザ ゼネラル ホスピタル コーポレーション 腫瘍サプレッサー遺伝子の機能検査
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
WO1995007708A2 (en) * 1993-09-13 1995-03-23 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US5550020A (en) * 1994-07-08 1996-08-27 Visible Genetics Inc. Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
US6974666B1 (en) * 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5753439A (en) * 1995-05-19 1998-05-19 Trustees Of Boston University Nucleic acid detection methods
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US5952178A (en) * 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US5830665A (en) * 1997-03-03 1998-11-03 Exact Laboratories, Inc. Contiguous genomic sequence scanning
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
WO2000050640A1 (en) 1999-02-25 2000-08-31 Exact Laboratories, Inc. Methods for preserving dna integrity
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
CA2394921A1 (en) 1999-12-07 2001-06-14 Anthony P. Shuber Supracolonic aerodigestive neoplasm detection
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
WO2003071252A2 (en) 2002-02-15 2003-08-28 Exact Sciences Corporation Methods for analysis of molecular events
US7981607B2 (en) 2004-08-27 2011-07-19 Esoterix Genetic Laboratories LLC Method for detecting recombinant event
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
JP4928311B2 (ja) * 2006-12-11 2012-05-09 本田技研工業株式会社 車両のドア及びその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
GB8712646D0 (en) * 1987-05-29 1987-07-01 Clayton Found Res Structural evidence

Also Published As

Publication number Publication date
DE3752360D1 (de) 2003-02-06
JP3051894B2 (ja) 2000-06-12
EP0608004A3 (en) 1994-08-10
EP0608004B1 (de) 2003-01-02
EP0608004A2 (de) 1994-07-27
EP0259031A3 (en) 1990-09-12
ES2063739T3 (es) 1995-01-16
JP3110372B2 (ja) 2000-11-20
AU600293B2 (en) 1990-08-09
JPH10337190A (ja) 1998-12-22
JPH10319013A (ja) 1998-12-04
JP2779161B2 (ja) 1998-07-23
JP2902362B2 (ja) 1999-06-07
ATE230442T1 (de) 2003-01-15
DE3752360T2 (de) 2004-02-12
JPH09121898A (ja) 1997-05-13
EP0259031A2 (de) 1988-03-09
ES2189795T3 (es) 2003-07-16
CA1341576C (en) 2008-07-08
JPS63119698A (ja) 1988-05-24
AU7676287A (en) 1988-05-19
DE3750738D1 (de) 1994-12-15
DE3750738T2 (de) 1995-06-01
EP0259031B1 (de) 1994-11-09

Similar Documents

Publication Publication Date Title
ATE113993T1 (de) Menschliche dns für die diagnose von glioma- retinae.
NO885456D0 (no) Diagnostisk elektrode.
DE3856167D1 (de) Behälter für die pathologische Gewebe-Untersuchung
DE3778948D1 (de) Teilchen, geeignet fuer die herstellung von tabletten als diagnostische reagenzien.
DE3886216D1 (de) Waschverfahren für blutzellen und behältereinheit dafür.
DE3777354D1 (de) Medizinischer verband.
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE3668704D1 (de) Fluoreszierende verbindungen und ihr biologischer diagnostischer zweck.
KR850007944U (ko) 심전계용 크립형전극
DE3783966D1 (de) Reagens zur pruefung von periodentalen erkrankungen.
DE3784479D1 (de) Diagnostisches hilfsmittel, seine herstellung und seine verwendung.
DE3769808D1 (de) Vorrichtung zur ueberwachung von okkultem blut.
DE3688562D1 (de) Einmal-elektrode zur patientenueberwachung.
DK28188D0 (da) Medicinsk diagnoseapparat
IT1213254B (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
DE3786077D1 (de) Ultraschalldiagnose-anordnung.
NO882950L (no) Diagnostisk test for stafylokokk-foraarsaket mastitt.
KR870016591U (ko) 모피쇼올
DE3789612D1 (de) Analytisches Element für die Vermessung von enzymatischer Aktivität.
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
DE3785804D1 (de) Komforme biomedizinische flachelektrode.
NO883626L (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
DE3888684D1 (de) Behandlung und diagnose von klauenseuche unter verwendung der basischen protease von bacteroides nodosus.
FI861093A0 (fi) Bioelektrisk patientmonitor.
IT1086463B (it) Densitometro per la determinazione quantitativa di frazioni proteiche separate per via elettroforetica,particolarmente per la diagnosi clinica